| CDSRF | chronic disease and sociodemographic risk factors |
|---|---|
| CSPINE | corticosteroid use, seropositive RA, peripheral joint destruction, involvement of cervical nerves, n... |
| DRC | damage risk criterion; dendritic reticulum cell; diagnostic reporting console; digitorenocerebral [s... |
| HARP | homeless and at-risk population |
| HRA | health record analyst; health risk appraisal; heart rate audiometry; hereditary renal adysplasia; hi... |
implicit behavior
| reduction nucleus | A nucleus that degenerates in the cell during the changes incident to fertilization. (05 Mar 2000) |
|---|---|
| reduction of chromosomes | The process during meiosis whereby one member of each homologous pair of chromosomes is distributed to a sperm or ovum; the diploid set of chromosomes (46 in humans) is thus reduced to the haploid set in each gamete; union of the sperm and ovum then restores the diploid or somatic number in the one-cell zygote. (05 Mar 2000) |
| reduction phase | The stage of nuclear changes in the sexual cells during which reduction of the chromosomes takes place; it embraces the cell generations of the spermatocytes and oocytes. Synonym: reduction phase. (05 Mar 2000) |
| reduction potential | The inherent tendency of a compound to act as an electron donor or an electron acceptor. Measured in volts. (09 Oct 1997) |
| closed reduction | The physical manipulation of a joint or bone externally (without making a surgical incision) to affect a joint relocation or more proper anatomic alignment of broken bone fragments. Closed reductions are often performed using intravenous analgesics, local anaesthetic nerve blocks or regional anaesthesia. (27 Sep 1997) |
| closed reduction of fractures | Reduction by manipulation of bone, without incision in the skin. (05 Mar 2000) |
| Motulsky dye reduction test | A test for glucose-6-phosphate dehydrogenase deficiency in the blood, using a mixture of brilliant cresyl blue, glucose-6-phosphate, and NADP. (05 Mar 2000) |
| pregnancy reduction, multifetal | Selective abortion of one or more embryos or foetuses in a multiple gestation pregnancy. The usual goal is to improve the outcome for the remaining embryos or foetuses. (12 Dec 1998) |
| Schmorl's ferric-ferricyanide reduction stain | <technique> A stain to test for reducing substances in tissues, including melanin, argentaffin granules, thyroid colloid, keratin, keratohyalin, and lipofuscin pigments; ferricyanide is converted into ferrocyanide which is converted to insoluble Prussian blue in the presence of ferric ions. (05 Mar 2000) |
| selective reduction | <obstetrics> A technique for intrauterine termination of one or more foetuses while leaving one or more foetuses undisturbed, usually in pregnancies with foetal anomalies or with multiple gestations. (05 Mar 2000) |
| source emission reduction plan | (SERP) A contingency plan developed to reduce emissions during an air quality emergency. (05 Dec 1998) |
| nitroblue tetrazolium reduction | <chemical> Nitroblue tetrazolium, a yellow dye, is taken up by phagocytosing neutrophils and reduced to insoluble formazan, which is deep blue, if the metabolic burst is normal. Reduction does not take place in chronic granulomatous disease. (18 Nov 1997) |
| internal reduction | The relocation of a joint or realignment of a fracture through a surgical incision. most internal reductions utilise general anaesthesia. (27 Sep 1997) |
| open reduction of fractures | Reduction by manipulation of bone, after incision in skin and muscle over the site of the fracture. (05 Mar 2000) |
| oxidation-reduction | A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs. (12 Dec 1998) |